NASDAQ : TIL
Instil Bio, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 6.8 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 46.12M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Selling, General & Admin | 22.43M | 27.22M | 44.21M | 47.55M | 69.34M | 51.31M |
| Research & Development | 14.51M | 25.69M | 15.75M | 42.99M | 136.83M | 103.96M |
| Operating Expenses | 36.95M | 52.91M | 59.96M | 90.54M | 206.17M | 155.27M |
| Operating Income | -36.95M | -52.91M | -59.96M | -90.54M | -206.17M | -155.27M |
| Interest Expense | -6.28M | -5.83M | -8.99M | -5.21M | -1.88M | |
| Interest & Investment Income | 2.95M | 3.86M | 6.99M | 8.87M | 3.65M | 80.00K |
| Other Non Operating Income (Expenses) | 8.60M | 9.18M | 1.41M | -575.00K | -564.00K | -1.27M |
| EBT Excluding Unusual Items | -31.68M | -45.70M | -60.55M | -87.46M | -204.96M | -156.46M |
| Merger & Restructuring Charges | -1.17M | -16.62M | -7.49M | -72.01M | -5.43M | |
| Impairment of Goodwill | -5.70M | |||||
| Asset Writedown | -1.93M | |||||
| Other Unusual Items | 2.57M | 948.00K | 3.91M | 3.38M | 2.88M | -294.00K |
| Pretax Income | -30.28M | -71.37M | -74.14M | -156.09M | -225.25M | -156.75M |
| Income Tax Expense | -2.07M | 39.00K | ||||
| Net Income | -30.28M | -71.37M | -74.14M | -156.09M | -223.18M | -156.79M |
| Net Income to Common | -30.28M | -71.37M | -74.14M | -156.09M | -223.18M | -156.79M |
| Shares Outstanding (Basic) | 6.78M | 6.67M | 6.51M | 6.50M | 6.48M | 5.30M |
| Shares Outstanding (Diluted) | 6.78M | 6.67M | 6.51M | 6.50M | 6.48M | 5.30M |
| EPS (Basic) | -4.47 | -10.70 | -11.39 | -24.00 | -34.46 | -29.59 |
| EPS (Diluted) | -4.47 | -10.70 | -11.39 | -24.00 | -34.46 | -29.59 |
| Free Cash Flow | -23.61M | -36.62M | -55.70M | -102.69M | -264.75M | -179.97M |
| Free Cash Flow Per Share | -3.48 | -5.49 | -8.55 | -15.79 | -40.88 | -33.96 |
| EBITDA | -36.66M | -52.37M | -56.35M | -85.78M | -200.18M | -152.51M |
| D&A For EBITDA | 284.00K | 534.00K | 3.61M | 4.76M | 5.99M | 2.75M |
| EBIT | -36.95M | -52.91M | -59.96M | -90.54M | -206.17M | -155.27M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 5.54M | 6.64M | 8.80M | 9.20M | 43.72M | 37.59M |
| Short-Term Investments | 64.14M | 69.49M | 104.51M | 141.16M | 217.20M | 416.51M |
| Trading Asset Securities | 1.05M | 2.20M | ||||
| Cash & Short-Term Investments | 69.68M | 76.13M | 113.31M | 151.41M | 263.12M | 454.10M |
| Other Receivables | 26.00K | 848.00K | 2.62M | |||
| Receivables | 26.00K | 848.00K | 2.62M | |||
| Prepaid Expenses | 1.57M | 2.04M | 5.74M | 7.85M | 6.26M | 9.92M |
| Restricted Cash | 254.00K | 166.00K | 1.83M | 1.50M | ||
| Other Current Assets | 76.00K | 112.24M | 959.00K | |||
| Total Current Assets | 71.61M | 191.43M | 124.47M | 160.76M | 269.38M | 464.02M |
| Property, Plant & Equipment | 113.93M | 364.00K | 130.34M | 141.07M | 209.34M | 122.00M |
| Long-Term Investments | 23.16M | |||||
| Goodwill | 5.72M | |||||
| Other Intangible Assets | 10.10M | |||||
| Other Long-Term Assets | 12.18M | 11.73M | 8.76M | 639.00K | 3.41M | 8.14M |
| Total Assets | 197.71M | 203.52M | 263.57M | 325.63M | 482.13M | 609.98M |
| Accounts Payable | 795.00K | 779.00K | 659.00K | 1.21M | 2.36M | 5.57M |
| Accrued Expenses | 1.96M | 3.54M | 3.48M | 4.27M | 9.30M | 21.45M |
| Current Portion of Leases | 393.00K | 372.00K | 1.68M | 1.75M | 2.38M | |
| Current Income Taxes Payable | 524.00K | |||||
| Other Current Liabilities | 155.00K | 155.00K | 2.07M | 3.33M | 18.75M | 13.81M |
| Total Current Liabilities | 3.31M | 4.84M | 7.90M | 10.56M | 32.79M | 41.36M |
| Long-Term Debt | 85.19M | 84.81M | 84.19M | 81.43M | 72.35M | |
| Long-Term Leases | 1.83M | 1.02M | 2.88M | 5.17M | ||
| Long-Term Deferred Tax Liabilities | 2.43M | |||||
| Other Long-Term Liabilities | 8.00K | 1.03M | 4.94M | 8.21M | 11.00M | |
| Total Liabilities | 90.33M | 89.66M | 94.13M | 99.80M | 118.52M | 54.78M |
| Additional Paid-In Capital | 842.96M | 840.94M | 824.78M | 807.16M | 788.99M | 757.00M |
| Retained Earnings | -734.99M | -726.49M | -655.12M | -580.98M | -424.89M | -201.72M |
| Comprehensive Income & Other | -587.00K | -583.00K | -228.00K | -348.00K | -493.00K | -87.00K |
| Total Common Equity | 107.38M | 113.87M | 169.44M | 225.83M | 363.61M | 555.20M |
| Shareholders' Equity | 107.38M | 113.87M | 169.44M | 225.83M | 363.61M | 555.20M |
| Total Liabilities & Equity | 197.71M | 203.52M | 263.57M | 325.63M | 482.13M | 609.98M |
| Total Debt | 87.42M | 85.18M | 86.89M | 86.05M | 79.90M | |
| Net Cash (Debt) | -17.74M | -9.05M | 26.43M | 65.36M | 183.22M | 454.10M |
| Net Cash Per Share | -2.62 | -1.36 | 4.06 | 10.05 | 28.29 | 85.68 |
| Filing Date Shares Outstanding | 6.78M | 6.78M | 6.53M | 6.50M | 6.50M | 6.46M |
| Total Common Shares Outstanding | 6.78M | 6.78M | 6.53M | 6.50M | 6.50M | 6.45M |
| Working Capital | 68.30M | 186.59M | 116.57M | 150.20M | 236.59M | 422.66M |
| Book Value Per Share | 15.83 | 16.79 | 25.96 | 34.72 | 55.91 | 86.06 |
| Tangible Book Value | 107.38M | 113.87M | 169.44M | 225.83M | 363.61M | 539.37M |
| Tangible Book Value Per Share | 15.83 | 16.79 | 25.96 | 34.72 | 55.91 | 83.61 |
| Land | 20.40M | 31.24M | 31.24M | 31.24M | 31.24M | |
| Buildings | 91.52M | 102.43M | 102.43M | 32.78M | 6.03M | |
| Machinery | 501.00K | 509.00K | 509.00K | 11.14M | 32.89M | 17.98M |
| Construction In Progress | 104.12M | 67.88M | ||||
| Leasehold Improvements | 1.42M | 4.34M | 1.84M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -30.28M | -71.37M | -74.14M | -156.09M | -223.18M | -156.79M |
| Depreciation & Amortization | 284.00K | 534.00K | 3.61M | 4.76M | 5.99M | 2.75M |
| Loss (Gain) From Sale of Assets | 2.00K | 343.00K | 377.00K | |||
| Asset Writedown & Restructuring Costs | 181.00K | 26.48M | 15.15M | 67.81M | 17.73M | |
| Loss (Gain) From Sale of Investments | 402.00K | -37.00K | -4.33M | -6.78M | -1.03M | |
| Stock-Based Compensation | 5.39M | 8.69M | 17.26M | 18.17M | 30.44M | 26.20M |
| Other Operating Activities | 333.00K | -355.00K | -991.00K | -1.26M | -555.00K | 1.35M |
| Change in Accounts Payable | 272.00K | 116.00K | -556.00K | -1.13M | -1.81M | 3.86M |
| Change in Other Net Operating Assets | -200.00K | -676.00K | -12.05M | -7.89M | -7.76M | 499.00K |
| Operating Cash Flow | -23.61M | -36.62M | -55.70M | -82.03M | -180.16M | -122.14M |
| Capital Expenditures | -20.66M | -84.59M | -57.83M | |||
| Sale of Property, Plant & Equipment | 14.00K | 432.00K | 866.00K | 1.56M | ||
| Investment in Securities | 31.23M | 35.04M | 64.09M | 60.23M | 200.30M | -416.56M |
| Other Investing Activities | -10.00M | -10.00M | -10.98M | -1.17M | ||
| Investing Cash Flow | 21.24M | 25.48M | 53.97M | 41.13M | 114.54M | -474.40M |
| Long-Term Debt Issued | 85.60M | 8.67M | 70.34M | |||
| Long-Term Debt Repaid | -82.84M | -587.00K | ||||
| Net Debt Issued (Repaid) | 2.76M | 8.08M | 70.34M | |||
| Issuance of Common Stock | 378.00K | 7.76M | 365.00K | 1.55M | 340.77M | |
| Other Financing Activities | -472.00K | -1.37M | -69.00K | |||
| Financing Cash Flow | 378.00K | 7.29M | 1.75M | 8.08M | 71.89M | 393.16M |
| Foreign Exchange Rate Adjustments | -48.00K | 20.00K | -94.00K | -201.00K | -637.00K | -304.00K |
| Net Cash Flow | -2.04M | -3.83M | -61.00K | -33.02M | 5.63M | -203.67M |
| Free Cash Flow | -23.61M | -36.62M | -55.70M | -102.69M | -264.75M | -179.97M |
| Free Cash Flow Per Share | -3.48 | -5.49 | -8.55 | -15.79 | -40.88 | -33.96 |
| Levered Free Cash Flow | 81.81M | -133.37M | -26.63M | -82.27M | -185.48M | -103.34M |
| Unlevered Free Cash Flow | 85.74M | -129.73M | -21.01M | -79.02M | -184.30M | -103.34M |
| Cash Interest Paid | 5.51M | 5.04M | 8.00M | 6.64M | 1.07M | |
| Change in Working Capital | 72.00K | -560.00K | -12.61M | -9.02M | -9.57M | 4.36M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 46.19M | 74.60M | 124.58M | 49.56M | 81.76M | 2.21B |
| Enterprise Value | 63.93M | 79.85M | 88.78M | -47.63M | -150.65M | 1.69B |
| Last Close Price | 6.80 | 11.00 | 19.09 | 7.62 | 12.60 | 342.20 |
| PB Ratio | 0.43 | 0.66 | 0.73 | 0.22 | 0.23 | 3.97 |
| P/TBV Ratio | 0.43 | 0.66 | 0.73 | 0.22 | 0.23 | 4.09 |
| Debt / Equity Ratio | 0.81 | 0.75 | 0.51 | 0.38 | 0.22 | |
| Net Debt / Equity Ratio | 0.17 | 0.08 | -0.16 | -0.29 | -0.50 | -0.82 |
| Net Debt / EBITDA Ratio | -0.48 | -0.17 | 0.47 | 0.76 | 0.92 | 2.98 |
| Net Debt / FCF Ratio | -0.75 | -0.25 | 0.47 | 0.64 | 0.69 | 2.52 |
| Quick Ratio | 21.09 | 15.89 | 14.68 | 14.34 | 8.03 | 10.98 |
| Current Ratio | 21.67 | 39.53 | 15.76 | 15.22 | 8.22 | 11.22 |
| Return on Equity (ROE) | -25.33% | -50.39% | -37.51% | -52.96% | -48.58% | -37.00% |
| Return on Assets (ROA) | -10.77% | -14.16% | -12.72% | -14.01% | -23.60% | -20.89% |
| Return on Capital Employed (ROCE) | -19.00% | -26.60% | -23.50% | -28.70% | -45.90% | -27.30% |
| Earnings Yield | -65.61% | -95.67% | -59.51% | -314.94% | -272.97% | -7.11% |
| FCF Yield | -51.20% | -49.09% | -44.71% | -207.21% | -323.82% | -8.16% |
| Buyback Yield / Dilution | -3.61% | -2.43% | -0.10% | -0.44% | -22.19% | -562.55% |